Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 9/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12775025 | 0.94 | TSHR (0.61) | TSHRHPGDALDH1A1CYP3A4ATM | |
| SCHEMBL332090 | 0.93 | TSHR (0.59) | TSHRHPGDALDH1A1CYP3A4ATM | |
| SCHEMBL13561215 | 0.91 | TSHR (0.54) | TSHRHPGDALDH1A1CYP3A4ATM | |
| SCHEMBL7761501 | 0.91 | TSHR (0.62) | TSHRHPGDALDH1A1CYP3A4ATM | |
| SCHEMBL28859870 | 0.90 | TSHR (0.56) | TSHRHPGDALDH1A1CYP3A4ATM | |
| SCHEMBL10656377 | 0.89 | TSHR (0.60) | TSHRHPGDALDH1A1CYP3A4ATM | |
| SCHEMBL9122872 | 0.88 | TSHR (0.62) | TSHRHPGDALDH1A1CYP3A4ATM | |
| SCHEMBL374776 | 0.88 | TSHR (0.57) | TSHRHPGDALDH1A1CYP3A4ATM | |
| SCHEMBL14175495 | 0.87 | TSHR (0.55) | TSHRHPGDALDH1A1CYP3A4ATM | |
| SCHEMBL22115841 | 0.86 | TSHR (0.69) | TSHRHPGDALDH1A1CYP3A4ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036025-B2 | Bio-electrode, method for manufacturing bio-electrode, and method for measuring biological signal | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-16 | — | — | US | disclosed |
| US-12030902-B2 | Polymer crosslinking agent, and high molecular weight polymer and composition using same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| US-20230348718-A1 | LIGHT-FILTERING MATERIALS FOR BIOMATERIAL INTEGRATION AND METHODS THEREOF | JOHNSON & JOHNSON VISION CARE, INC. | 2023-11-02 | — | — | US | disclosed |
| US-11783958-B2 | Conductive wiring material composition, conductive wiring substrate and method for producing conductive wiring substrate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
| US-20230193138-A1 | EMULSIFIER AND EMULSION COMPOSITION CONTAINING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-22 | — | — | US | disclosed |
| US-20230174701-A1 | DIBLOCK COPOLYMER, METHOD FOR PRODUCING DIBLOCK COPOLYMER, AND USE OF DIBLOCK COPOLYMER | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230193138-A1 | EMULSIFIER AND EMULSION COMPOSITION CONTAINING SAME | APOB, F12, H1-0 | TSHR 3000/4885HPGD 4183/4885ALDH1A1 3192/4885 |
| US-12030902-B2 | Polymer crosslinking agent, and high molecular weight polymer and composition using same | SMCHD1, MUS81, MGLL | TSHR 4056/4885HPGD 565/4885ALDH1A1 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.